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National Institutes of Health of the endoND is characterized by nine highly conserved
amino acid residues known as the RNase III signatureFrederick, Maryland 21702
motif (Figure 1B).
RNase III influences gene expression from mRNA as
either a dsRNA-processing enzyme or a dsRNA binding
Summary protein (Dasgupta et al., 1998; Oppenheim et al., 1993).
As a dsRNA-processing enzyme, RNase III degrades
Ribonuclease III (RNase III) represents a family of dou- both natural and synthetic dsRNA to small duplex prod-
ble-stranded RNA (dsRNA) endonucleases. The simplest ucts averaging 10–18 base pairs (bp) in length (Court,
bacterial enzyme contains an endonuclease domain 1993; Dunn, 1982; Robertson, 1982; Robertson and Dunn,
(endoND) and a dsRNA binding domain (dsRBD). 1975). As a dsRNA binding protein, Ec-RNase III binds
RNase III can affect RNA structure and gene expres- certain substrates without processing and still influ-
sion in either of two ways: as a dsRNA-processing ences gene expression (Dasgupta et al., 1998; Oppen-
enzyme that cleaves dsRNA, or as a dsRNA binding heim et al., 1993). RNase III has received a significant
protein that binds but does not cleave dsRNA. We pre- amount of attention as a dsRNA-processing enzyme but
viously determined the endoND structure of Aquifex aeo- not much as a dsRNA binding protein. Two forms of the
licus RNase III (Aa-RNase III) and modeled a catalytic RNase III·dsRNA complex may exist. One takes the form
complex of full-length Aa-RNase III with dsRNA. Here, of a catalytic complex in which the bound dsRNA is
we present the crystal structure of Aa-RNase III in contacting the endoND active center (Blaszczyk et al.,
complex with dsRNA, revealing a noncatalytic assem- 2001). The other takes the form of a noncatalytic assem-
bly. The major differences between the two functional bly in which the endoND active center may not be asso-
forms of RNase III·dsRNA are the conformation of the ciated with the bound dsRNA. Ten missense mutations
protein and the orientation and location of dsRNA. The that cause defects in Ec-RNase III have been identified
flexibility of a 7 residue linker between the endoND and their effects elucidated (Figure 1B), among which
and dsRBD enables the transition between these two rnc70 (E117K, corresponding to E110K in Aa-RNase III)
forms. creates a mutant RNase III protein with impaired endo-
nucleolytic activity but without blocking its ability to
recognize and bind dsRNA in vivo or in vitro (Court,Introduction
1993; Dasgupta et al., 1998; Inada et al., 1989; Li and
Nicholson, 1996). Therefore, this mutant may form aDouble-stranded RNA (dsRNA) influences critical cell
noncatalytic assembly with dsRNA.functions. Ribonuclease III (RNase III) belongs to the
Structural information that relates to RNase III hasfamily of dsRNA-specific endoribonucleases (Court, 1993;
been accumulating since 1995. In addition to the NMRRobertson et al., 1968) and has been found in all studied
solution structures of dsRBDs in Ec-RNase III and otherprokaryotes and eukaryotes (Court, 1993; Filippov et al.,
dsRNA binding proteins (Bycroft et al., 1995; Kharrat et2000; Krainer, 1997; Nicholson, 1996, 1999). RNase IIIs
al., 1995; Nanduri et al., 1998; Ramos et al., 2000), arange in length between 200 and 2000 amino acid
crystal structure was determined for a dsRBD of Xeno-residues (Figure 1A) and play important roles in RNA
pus laevis RNA binding protein A in complex with dsRNAprocessing, posttranscriptional gene expression control
(Xl-dsRBD·dsRNA) (Ryter and Schultz, 1998). We pre-(Court, 1993; Krainer, 1997; Wu et al., 2000), cellular
viously reported the endoND structure of Aquifex aeoli-defense against viral infection (Court, 1993; Robertson
cus RNase III in its ligand-free form (Aa-endoND) andet al., 1968), and RNA interference (RNAi) (Bernstein et
in complex with Mn2 (Aa-endoND·Mn2), providing theal., 2001; Carthew, 2001). Escherichia coli RNase III (Ec-
first glimpse at the RNase III active site (Blaszczyk etRNase III) is the simplest member of the family, con-
al., 2001; Zamore, 2001). Recently, the crystal structuresisting of an endonuclease domain (endoND) followed
of a hypothetical RNase III (Tm1102) from Thermotogaby a dsRNA binding domain (dsRBD). RNase III from
maritima (Tm-RNase III) was determined by the JointSaccharomyces cerevisiae (Sc-Rnt1p) is composed of
Center for Structural Genomics (PDB entry 1O0W, Figurean endoND, a dsRBD, and an additional N-terminal do-
1B). Here, we present two crystal structures: that of themain of 200 amino acid residues with no known func-
wild-type endoND of Aa-RNase III in complex with Mg2tion (Lamontagne et al., 2001). Drosophila melanogaster
(Aa-endoND·Mg2) and that of full-length Aa-RNase IIIRNase III (Dm-Drosha) has two endoNDs, one dsRBD,
(E110K) with bound dsRNA (Aa-E110K·dsRNA). The se-and a larger N-terminal extension of 900 amino acid
quence of the dsRNA we cocrystallized with Aa-E110K
is the same as that used in Xl-dsRBD·dsRNA (Ryter
and Schultz, 1998), which allows a direct comparison of*Correspondence: jix@ncifcrf.gov
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Figure 1. RNase III Proteins and Sequences
(A) Representatives of RNase III proteins: Hs-Dicer (1924 amino acid residues, GenBank AB028449), Dm-Drosha (1327 amino acid residues,
SWISS-PROT Q9XYN5), Sc-Rnt1p (471 amino acid residues, SWISS-PROT Q02555), and Ec-RNase III (226 amino acid residues, SWISS-PROT
P05797). The scale on top indicates the lengths of polypeptide chains. Cyan box represents helicase domain, green box PAZ domain, red
box endoND, and blue box dsRBD. Additional domain structures in Hs-Dicer and Dm-Drosha are not shown.
(B) Sequence alignment of Aa-RNase III (SWISS-PROT O67082), Tm-RNase III (SWISS-PROT Q9X0I6), and Ec-RNase III (SWISS-PROT P05797).
Secondary structural elements are indicated with shading, helices in green and strands in blue. Boxed amino acid residues at the C termini
are not observed. Underlined is the RNase III signature motif. Shaded in red are seven Ec-RNase III residues for which data is available for
ten mutant proteins, including (1) G44D (rnc105 [Bardwell et al., 1989; Nashimoto and Uchida, 1985]); (2) I47N (rnc; H.K. Peters, N. Costantino,
and D.L.C., unpublished data); (3) G97E (rnc97 [Davidov et al., 1993]); (4) E117K (rnc70 [Dasgupta et al., 1998; Inada et al., 1989; Li and
Nicholson, 1996]), E117A (Li and Nicholson, 1996), and E117Q and E117D (Sun and Nicholson, 2001); (5) Q153P (rnc10 [Inada and Nakamura,
1995]); (6) D155E (rnc7 [Inada and Nakamura, 1995]), and (7) A211V (rev3 [Nashimoto and Uchida, 1985]).
dsRBD-dsRNA interactions between these two protein and Mn2 occupy the same metal binding site with iden-
tical coordination that involves E40, D44, D107, andtypes.
E110.
Results and Discussion
The E110K Mutation Influences the Binding
of Both Mg2 and dsRNAThe Mg2 and Mn2 Ions Occupy the Same Binding
Site with Identical Coordination As we previously proposed, six negatively charged side
chains (E37, E40, D44, E64, D107, and E110) are clus-A divalent metal ion (preferably Mg2) is required for
the reaction catalyzed by RNase III (Dunn, 1982; Li and tered at each end of the catalytic valley upon dimeriza-
tion of the endoND, forming two compound active cen-Nicholson, 1996; Robertson et al., 1968; Sun and Nichol-
son, 2001). A comparison between the crystal structure ters (Blaszczyk et al., 2001). The same general structure
of the endoND is found in the Aa-E110K·dsRNA com-of Aa-endoND·Mn2 (Blaszczyk et al., 2001) and that of
Aa-endoND·Mg2 (this work) demonstrates that Mg2 plex. The electron density within one active center for
Structure of RNase III in Complex with dsRNA
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Figure 2. Impact of E110K Mutation on the Mg2 Binding Site of Aa-RNase III
(A) Stereoview of the final 2Fo-Fc electron density contoured at 1 (green net) for the Aa-E110K mutation site. Residues E40, D44, D107, and
K110, and two water molecules are illustrated as ball-and-stick models in atomic colors (gray carbon, blue nitrogen, and red oxygen).
(B) Stereoview showing the superposition of Aa-endoND·Mg2 (in cyan) and Aa-E110K·dsRNA (in atomic colors). The coordination bonds of
Mg2 are shown as solid lines and hydrogen bonds as dashed lines.
the mutation site in the Aa-E110K·dsRNA structure is Aa-E110K appear unfavorable for the binding of dsRNA
within the active center, thereby giving rise to a distinctshown in Figure 2A. Although the Aa-E110K·dsRNA
crystal was grown in the presence of 1.5 mM Mg2 (Ex- dsRNA binding form.
perimental Procedures), no Mg2 was observed in the
Aa-E110K·dsRNA structure. The mutation has two direct The dsRNA in Aa-E110K·dsRNA Is Not Bound in
the Catalytic Valleyeffects on the local environment relative to wild-type
Aa-RNase III. First, it eliminates one negative charge As described previously (Ryter and Schultz, 1998), the
self-complementary RNA 10-mer (GGCGCGCGCC) formsfrom each active center. Second, atom NZ of K110 es-
sentially occludes the Mg2 binding site and forms a 10 bp dsRNA helices, which stack end-to-end as a pseu-
docontinuous helix in the crystal lattice. Each Aa-E110Khydrogen bond network involving E40, D44, D107, and
two water molecules (Figure 2B), rendering this environ- monomer binds two consecutive 10 bp dsRNA helices
in the pseudocontinuous helix, forming the content ofment in Aa-E110K no longer suitable for the binding
of Mg2. Without the required Mg2 ion, the endoND the asymmetric unit. Because RNase III functions as a
dimer, a dimer of the Aa-E110K·dsRNA complex iscatalytic centers of Aa-E110K (Ec-E117K) cannot be
functional in terms of RNA cleavage. Since the divalent shown in Figure 3. The secondary structure assignment
for the entire polypeptide chain is diagrammed in Figuremetal ion enhances dsRNA binding (Li and Nicholson,
1996; Sun and Nicholson, 2001), without bound Mg2, 1B and labeled in part in Figure 3A. As previously estab-
lished (Blaszczyk et al., 2001), seven -helices and onethe remaining negative charges at the active center of
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Figure 3. Overall Structure of Aa-E110K·dsRNA
(A) Illustration of a biological dimer of the Aa-E110K·dsRNA complex. The crystallographically independent molecule and its symmetry mate
are indicated by N-C, and N-C, respectively. Secondary structural elements are labeled for those in dsRBD and 3 in the endoND. The
endoND, dsRBD, dsRNA, endoNDsym, dsRBDsym, and dsRNAsym are colored yellow, green, green, cyan, blue, and blue, respectively. The RNase
III signature motif at the N terminus of 3 is highlighted in red. Helices,  strands and loops are drawn as spirals, arrows, and pipes, respectively.
(B) A different view of dimeric Aa-E110K·dsRNA related to the view in (A) by a 90 rotation around the vertical axis.
310 helix are the building blocks for the Aa-endoND. The hydrogen bonds between dsRNA and the two endoNDs
involve three types of nucleotide atoms (O2, O3, andendoND of Tm-RNase III (PDB entry 1O0W) contains
two more -helices and one more 310 helix (Figure 1B), O2P) and 6 amino acid side chains (N61, R63, K32, K96,
R97, and K99). In addition, six water molecules mediatewhereas the secondary structural composition of the
dsRBD is conserved between the Aa- and Tm-dsRBD additional hydrogen bonds between the dsRBD and
dsRNA.(Figure 1B).
The crystal structure of Aa-E110K·dsRNA has three The dsRNA helices in both Aa-E110K·dsRNA (this
work) and Xl-dsRBD·dsRNA (Ryter and Schultz, 1998)features. First, each dsRBD binds a different dsRNA
helix. Second, neither of the two dsRNA helices associ- are formed by the same RNA 10-mer GGCGCGCGCC,
permitting a direct comparison of dsRBD-dsRNA inter-ated with the dimer is bound in the catalytic valley.
Third, the two resulting dsRBD·dsRNA complexes are actions in the two complexes. First of all, a difference
exists in the relative positioning of the dsRNA with re-perpendicular to the 3 helices and the catalytic valley
(Figure 3). The E110K mutation appears responsible for spect to the dsRBD, which can be seen when the two
structures are aligned using dsRBD C positions. It ap-the fact that the dsRNA is not bound within the catalytic
valley and thus cannot be processed. Therefore, the pears that the dsRNA rotates differentially along its long
axis by almost 1 bp while maintaining its interactionsE110K mutation acts as a catalytic antideterminant of
RNase III, uncoupling the dsRNA binding and pro- with the dsRBD (Figure 4A). Second, Aa-E110K·dsRNA
has fewer water-mediated hydrogen bonds betweencessing abilities of the enzyme.
dsRBD and dsRNA than Xl-dsRBD·dsRNA (Ryter and
Schultz, 1998). Third, in Aa-E110K·dsRNA, there are 25The dsRBD Plays the Most Important Role
in the Binding of dsRNA direct hydrogen bonds between dsRNA and dsRBD and
5 of these involve nucleotide base functional groups;The interaction between the polypeptides and one
dsRNA pseudoduplex involves residues on one of the whereas in Xl-dsRBD·dsRNA, there are only 10 direct
hydrogen bonds and 2 involve nucleotide base atomsdsRBD and both endoNDs of a dimeric molecule (Figure
3). Upon dsRNA binding, the buried surface between (Figure 4B). Looking at these interactions more closely,
we find that three Aa-dsRBD residues, Q157, Q161, andthe substrate and protein is approximately 1600, 200,
and 400 A˚2 for the dsRBD, the endoND of the same H179, form the five direct hydrogen bonds with guanine
base groups. Q157 in Aa-dsRBD corresponds to Q118peptide chain, and the endoND from the other chain,
respectively. Accordingly, the three polypeptides con- in Xl-dsRBD. However, Q157Aa-dsRBD binds a Gua while
Q118Xl-dsRBD recognizes a Cyt (Figure 4B). H179 in Aa-tribute to the formation of 25, 3, and 4 direct hydrogen
bonds with the dsRNA, respectively. Among the 25 di- dsRBD corresponds to P140 in Xl-dsRBD, and similarly,
H179Aa-dsRBD and P140Xl-dsRBD use their carbonyl oxygenrect hydrogen bonds between the dsRBD and dsRNA,
5 involve guanine base functional groups. The seven atom for a direct hydrogen bond formation with atom
Structure of RNase III in Complex with dsRNA
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Figure 4. The dsRBD-dsRNA Interaction
(A) Stereoview showing the superposition of the Aa-dsRBD·dsRNA portion (in orange) of Aa-E110K·dsRNA (this work) with Xl-dsRBD·dsRNA
(in cyan [Ryter and Schultz, 1998]) on the basis of dsRBD C alignment.
(B) Stereoview illustrating the recognition of nucleotide base functional groups by dsRBD residues. Aa-E110K residues Q157, Q161, and H179
(in orange) correspond to Xl-dsRBD residues Q118, V122, and P140 (in cyan), respectively.
N2 of a guanine base. Nevertheless, the guanines recog- sumably nucleotide sequence independent (Krovat and
Jantsch, 1996; Manche et al., 1992; Polson and Bass,nized by H179Aa-dsRBD and P140Xl-dsRBD are from opposite
RNA strands (Figure 4B). Q161 of Aa-dsRBD binds func- 1994; Ryter and Schultz, 1998). On the basis of the crys-
tal structures of Aa-E110K·dsRNA (this work) and Xl-tional groups N2 and N3 of another guanine (Figure 4B),
which is unique for Aa-dsRBD because Q161 corre- dsRBD·dsRNA (Ryter and Schultz, 1998), it appears that
Q157Aa-dsRBD recognizes either a Gua or a Cyt, andsponds to a valine residue in Xl-dsRBD.
Interactions between the dsRBD and dsRNA are pre- H179Aa-dsRBD recognizes a Gua. If any RNA sequence
Structure
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Figure 5. Comparison of Full-Length RNase III Model and Structures
(A) The crystal structure of Aa-E110K·dsRNA (this work).
(B) The model of Aa-RNase III·dsRNA (Blaszczyk et al., 2001). The dsRNA is illustrated as vdw space-filling models in atomic color scheme
(carbon in light gray, nitrogen in blue, and oxygen in red). One Aa-E110K chain of the dimer is colored in orange and the other in cyan, and
the dsRBD is highlighted with dark gray surfaces.
(C) The alignment, using endoND C positions, of the crystal structure of Aa-E110K·dsRNA (in cyan; this work), the model of Aa-RNase
III·dsRNA (in orange [Blaszczyk et al., 2001]) and the crystal structure of ligand-free Tm-RNase III (in red, PDB entry 1O0W). The dsRNA is
not shown for clarity. The molecular orientation is related to those in (A) and (B) by a 90 rotation around the horizontal axis for an optimal
view of the flexible linker between the endoND and dsRBD.
specificity exists for the dsRBD of RNase III, it could only a dsRNA-processing complex, whereas our crystal struc-
ture of Aa-E110K·dsRNA (this work) may represent thebe provided by the highly conserved residue Q161Aa-dsRBD.
dsRNA-bound form of RNase III as a noncatalytic as-
sembly. Three major differences exist between the twoStructural Basis of the Genetically Important
Linker between the EndoND and dsRBD forms. First, although the conformations of individual
domains are nearly identical, the relative orientationsOur model of Aa-RNase III·dsRNA (Blaszczyk et al.,
2001) suggests the dsRNA-bound form of RNase III as of the endoND and dsRBD are dramatically different
Structure of RNase III in Complex with dsRNA
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(Figures 5A and 5B). Second, in the model of AaRNase still be functional but the respective CIII and Int mRNA
may not be bound in the valley that contains the activeIII·dsRNA (Blaszczyk et al., 2001), the dsRNA substrate
is bound in the catalytic valley; whereas, in the crystal centers. A special structural motif in the RNA of these
two genes might act as an antideterminant for dsRNAstructure of Aa-E110K·dsRNA, neither of the two dsRNA
helices is (Figures 5A and 5B). Third, in the model of processing. The structure of this RNA motif remains to
be seen. Very recently, the first direct evidence of RNAAaRNase III·dsRNA (Blaszczyk et al., 2001), two dsRBD
are parallel to the valley and interact with the same structure-dependent uncoupling of substrate recogni-
tion and cleavage by the wild-type Ec-RNase III wasdsRNA helix (Figure 5B). In the crystal structure of Aa-
E110K·dsRNA, however, each dsRBD binds a different reported; the R1.1[CL3B], a dsRNA mutant derived from
the T7 phage R1.1 RNase III substrate, was selected todsRNA helix and the resulting dsRBD·dsRNA complexes
are perpendicular to the valley (Figure 5A). This 90 be resistant to cleavage in vitro but to retain binding
affinity. This mutant RNA contains a special bulge-helix-difference in the orientation of dsRNA is readily ex-
plained if the linker between the endoND and dsRBD bulge motif that may act as an antideterminant for cata-
lytic processing (Calin-Jageman and Nicholson, 2003).is flexible, which is suggested by available structural
information. Figure 5C depicts the superposition of Aa- In light of the structure of Aa-E110K·dsRNA, the bulge-
helix-bulge motif in the R1.1[CL3B] may act by blockingE110K·dsRNA (this work), Aa-RNase III·dsRNA (Blasz-
czyk et al., 2001), and Tm-RNase III (PDB entry 1O0W), the binding of dsRNA in the valley that contains active
centers. Therefore, the catalytic antideterminants em-demonstrating that the flexible linker between the en-
doND and dsRBD (145EGRVKKD151 and 162KGEMLFD168 in bedded in the dsRNA may be anti endoND but not anti
dsRBD, which may also be the case in ethidium-depen-Aa- and Tm-RNase III, respectively, Figure 1B) allows
the dsRBD to rotate and shift dramatically with respect dent uncoupling of substrate binding and cleavage by
Ec-RNase III (Calin-Jageman et al., 2001) in which twoto the endoND. We believe that this flexible linker en-
ables RNase III to assume at least two distinct dsRNA ethidium binding sites exist in the R1.1 RNA and the
site-specific binding of ethidium to the RNA substratebinding modes represented by our model of Aa-RNase
III·dsRNA on the one hand and by the crystal structure perturbs substrate recognition by the endoND.
The catalytic antideterminant of RNase III uncouplesof Aa-E110K·dsRNA on the other. These two modes of
dsRNA binding affect posttranscriptional gene expres- the dsRNA binding and processing activities. It can be
either a special structural motif embedded in dsRNAsion by distinct mechanisms. As a dsRNA-processing
enzyme, RNase III binds dsRNA in the valley where the (Calin-Jageman et al., 2001; Calin-Jageman and Nichol-
son, 2003) or a defective mutation in the endoND (thisactive centers are located, allowing the substrate to be
processed. As a dsRNA binding protein, RNase III binds work). In both cases, it is the interaction between the
endoND catalytic valley and the dsRNA that is disrupted.dsRNA without processing and influences gene expres-
sion by site-specific dsRNA binding (Calin-Jageman and
Experimental ProceduresNicholson, 2003; Court, 1993; Dasgupta et al., 1998). In
this binding mode as seen in the crystal structure of Aa-
Protein Expression and Purification
E110K·dsRNA, the protein-bound dsRNA is far away The Aa-endoND was overproduced in E. coli and purified as de-
from the enzymatic active centers and thus cannot be scribed (Blaszczyk et al., 2001). The open reading frame (ORF) en-
coding full-length Aa-RNase III (GenBank accession: AAC07049)processed.
was amplified from genomic DNA by the polymerase chain reactionAmong the ten missense mutations that cause defects
(PCR) using the following oligonucleotide primers: 5-GGG GAC AAGin Ec-RNase III, rnc10 (Q153P) and rnc7 (D155E) (Inada
TTT GTA CAA AAA AGC AGG CTT TAA GAA GGA GAT ATA CATand Nakamura, 1995) are located in the linker region
ATG AAA ATG TTG GAG CAA CTT G-3 and 5-GGG GAC CAC TTT
(Figure 1). It is readily explainable if the dsRNA-bound GTA CAA GAA AGC TGG GTT ATT ATT CTG ATT CCT CCA GTA ATT
form as seen in the Aa-E110K·dsRNA complex is also T-3. The PCR amplicon was inserted into pDONR201 (Invitrogen) by
recombinational cloning. Next, E110 was changed to Lys by site-an intermediate toward the processing form as seen in
directed mutagenesis and the entire sequence confirmed experi-our model (Blaszczyk et al., 2001). We speculate that
mentally. Finally, the Aa-E110K RNase III ORF was recombined intothe wild-type RNase III dimer in the cell first binds a
pDEST-42 (Invitrogen) to generate the plasmid expression vectordsRNA through one of its two dsRBDs. If the dsRNA
pHPK1409, which produces untagged Aa-E110K RNase III under
has sufficient length (at least two helical turns) and does the control of the bacteriophage T7 promoter. The Aa-E110K RNase
not contain antideterminants (see below for details), an III was produced in BL21(DE3)-RIL cells (Stratagene) at 30C for 18
hr in LB broth supplemented with 100 g/ml ampicillin, 35 g/mlisomerization to the processing form of the enzyme may
chloramphenicol, and 0.2% glucose. Cells were pelleted by centrifu-occur. This isomerization step is dependent upon the
gation and stored at 80C.flexible linker between the endoND and the dsRBD as
Unless otherwise stated, all procedures were performed at 4C.well as increased binding affinity to the dsRNA helix
E. coli cell paste was suspended in ice-cold 50 mM sodium phos-
afforded by its interaction with the other dsRBD and the phate (pH 8.0), 25 mM NaCl buffer (buffer A) containing 1 mM ben-
catalytic valley of the endoND. zamidine and Complete EDTA-free protease inhibitor cocktail tab-
lets (Roche), and disrupted with an APV Gaulin Model G1000
homogenizer at 10,000 psi. The homogenate was centrifuged at
20,000	 g for 30 min, and the supernatant was heat treated at 80CCatalytic Antideterminants of RNase III
for 30 min. After pelleting the insoluble material by centrifugation,The positive expression of CIII and Int in bacteriophage
the supernatant was filtered through a 0.22 m polyethersulfone

 are two examples whose genetic control may be ex-
membrane and applied to a HiPrep 16/10 SP FF column (Amersham
erted by site-specific dsRNA binding of RNase III in the Biosciences) equilibrated with buffer A. The column was washed
absence of processing (Guarneros, 1988; Oppenheim et with 10 column volumes of buffer A and eluted with a linear gradient
of NaCl from 25 mM to 1 M. Fractions containing recombinant pro-al., 1993). In these two special cases, the endoND may
Structure
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Table 1. Data Collection, Structure Determination, and Refinement Statistics
Aa-endoND·Mg2 Aa-E110K·dsRNA
Crystal
Shape Block Needle
Dimensions (mm) 0.15, 0.15, 0.20 0.03, 0.05, 0.25
X-Ray Data
Radiation source X9B, NSLS 22-ID, APS
Detector type ADSC Quantum-4 CCD Bruker Proteum-300 CCD
Wavelength (A˚) 1.045 1.000
Space group P21 C2221
Unit-cell parameters
a (A˚) 49.74 58.29
b (A˚) 140.86 118.14
c (A˚) 49.75 106.67
 (o) 117.29 90.0
Resolution (A˚) 30.0–2.30 50.0–2.15
Measured reflections 68,942 95,376
Unique reflections 24,431 18,881
Completeness (%), 89.4/87.4 92.3/58.3
overall/last shella
Rmergeb, overall/last shell 0.076/0.279 0.058/0.262
I/(I), overall/last shell 13.9/3.7 22.0/1.8
Molecular Replacement
Search model PDB entry 1I4S PDB entry 1I4S
Correlation coefficient 0.61 0.43
R factor 0.39 0.47
Refinement and Statistics
Reflections in refinement 22,942 17,624
Reflections for Rfree calculation 1,248 1,091
No. residues/protein atoms 594/4,929 220/1,838
No. heterogen atoms 4 (Mg2) 848 (RNA), 8 (Tris)
No. water oxygen atoms 675 236
Final Rfree 0.255 0.242
Final R factor 0.215 0.192
Rms deviation (A˚)
Bond lengths 0.004 0.005
Bond angles 0.016 0.026
Estimated coordinate error (A˚) 0.25 0.26
Overall Biso (A˚2) 34.6 47.2
Wilson B factor (A˚) 32.8 44.7
Ramachandran statistics (%):
Most favored φ/ values 91.8 96.1
Disallowed φ/ values 0.0 0.0
a 2.38–2.30 and 2.23–2.15 A˚ for Aa-endoND·Mg2 and Aa-E110K·dsRNA, respectively.
b Rmerge  |(I  I)|/(I), where I is the observed intensity.
tein were pooled, concentrated using an YM10 membrane (Amicon), RNA 10-mer GGCGCGCGCC
The self-complementary RNA 10-mer (GGCGCGCGCC) (Ryter andand fractionated on a HiLoad 26/60 Superdex 75 pg column (Amer-
sham Biosciences) equilibrated in 25 mM Tris (pH 7.2), 600 mM NaCl Schultz, 1998) was purchased from the Keystone Labs (Camarillo,
CA) and dissolved at 0.75 mM concentration in 25 mM Tris-HCl (pHbuffer. Fractions containing Aa-E110K were pooled and diluted with
a 50 mM Tris (pH 7.5) buffer to reduce the NaCl concentration to 7.2) buffer containing 0.2 M NaCl.
300 mM. The sample was applied to a 15 ml AGPoly(I)·Poly(C) Type
6 column (Amersham Biosciences) equilibrated with 50 mM Tris (pH Crystallization and X-Ray Diffraction Data Acquisition
Crystals were grown using the hanging-drop vapor diffusion method7.5), 300 mM NaCl buffer. The column was washed extensively with
equilibration buffer until a stable baseline was reached, then eluted at 19C  1C. The drops contained equal volumes of protein and
reservoir solutions. For Aa-endoND·Mg2, the protein concentrationwith a linear gradient of NaCl from 0.3 to 1 M. Fractions containing
recombinant protein were pooled, concentrated, and subjected to was 13 mg/ml in 25 mM Tris-HCl (pH 7.5) buffer containing 600 mM
NaCl and 1.5 mM MgCl2, and the reservoir solution was composeda second round of size exclusion chromatography as described
above. The final product was diluted with a 25 mM Tris (pH 7.2) buffer of 30% (w/v) PEG 4000 and 0.2 M sodium acetate in 100 mM Tris-
HCl (pH 8.5) buffer. For Aa-E110K·dsRNA, the protein concentrationto reduce the NaCl concentration to 300 mM and concentrated
to 17.4 mg/ml (determined spectrophotometrically using a molar was 10 mg/ml and the RNA concentration was 0.075 mM in 25 mM
Tris-HCl (pH 7.2) containing 200 mM NaCl and 1.5 mM MgCl2, andextinction coefficient of 24,180 M1cm1). Aliquots were flash-frozen
in liquid nitrogen and stored at 80C until use. The Aa-E110K the reservoir solution was composed of 24% (w/v) PEG 4000, 0.4
M imidazolel, and 0.16 M ammonium acetate in 100 mM Tris-HClprotein was judged to be 95% pure by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. The molecular weight was con- (pH 8.5) buffer. Data processing was carried out with the HKL2000
program suite (Otwinowski and Minor, 1997). Crystal data and pro-firmed by electrospray mass spectrometry.
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cessing statistics are summarized in Table 1. Further data pro- Calin-Jageman, I., Amarasinghe, A.K., and Nicholson, A.W. (2001).
Ethidium-dependent uncoupling of substrate binding and cleavagecessing was carried out with the CCP4 suite (CCP4, 1994) for struc-
ture determination and refinement. by Escherichia coli ribonuclease III. Nucleic Acids Res. 29, 1915–
1925.
Structure Determination and Refinement Carthew, R.W. (2001). Gene silencing by double-stranded RNA. Curr.
The structures of Aa-endoND·Mg2 and Aa-E110K·dsRNA were de- Opin. Cell Biol. 13, 244–248.
termined with the molecular replacement program AMoRe (Navaza, CCP4 (Collaborative Computational Project 4) (1994). The CCP4
1994) using X-ray diffraction data within the resolution range of suite: programs for protein crystallography. Acta Crystallogr. D 50,
10–4 A˚. For the Aa-endoND·Mg2 structure, the dimer of ligand-free 760–763.
Aa-endoND structure (Blaszczyk et al., 2001) was the search model.
Court, D. (1993). RNA processing and degradation by RNase III. In
For the Aa-E110K·dsRNA structure, a monomer of ligand-free Aa-
Control of Messenger RNA Stability, J.G. Belasco and G. Braverman,
endoND structure (Blaszczyk et al., 2001) was the search model.
eds. (New York: Academic Press), pp. 71–116.
Solvent molecules were excluded from the search models. The par-
Dasgupta, S., Fernandez, L., Kameyama, L., Inada, T., Nakamura,tial structure of Aa-E110K·dsRNA, containing the endoND only, was
Y., Pappas, A., and Court, D.L. (1998). Genetic uncoupling of thesubject to rigid body refinement, energy minimization, and grouped
dsRNA-binding and RNA cleavage activities of the Escherichia coliB factor refinement followed by difference Fourier synthesis, which
endoribonuclease RNase III - the effect of dsRNA binding on generevealed the position of dsRBD and dsRNA. Accordingly, a complete
expression. Mol. Microbiol. 28, 629–640.model of Aa-E110K·dsRNA was built, consisting of an Aa-E110K
chain and two 10 bp dsRNA helices. The crystal structure of Aa- Davidov, Y., Rahat, A., Flechner, I., and Pines, O. (1993). Character-
ization of the rnc-97 mutation of RNase III: a glycine to glutamateendoND·Mg2 was initially refined with the simulated annealing pro-
cedure (Bru¨nger and Rice, 1997) of CNS (Bru¨nger et al., 1998) fol- substitution increases the requirement for magnesium ions. J. Gen.
Microbiol. 139, 717–724.lowed by least-squares refinement with SHELXL (Sheldrick and
Schneider, 1997). The refinement of Aa-E110K·dsRNA was carried Dunn, J.J. (1982). Ribonuclease III. In The Enzymes, P. Boyer, ed.
out with CNS (Bru¨nger et al., 1998) only. Bulk solvent correction (New York: Academic Press), pp. 485–499.
was employed during the refinement. All graphics work was carried
Esnouf, R.M. (1997). An extensively modified version of MolScript
out using O (Jones et al., 1991). The refined structures were as-
that includes greatly enhanced coloring capabilities. J. Mol. Graph.
sessed using PROCHECK (Laskowski et al., 1993). Illustrations were
Model. 15, 112–113, 132–134.
generated with program packages MOLSCRIPT (Kraulis, 1991),
Filippov, V., Solovyev, V., Filippova, M., and Gill, S.S. (2000). A novelBOBSCRIPT (Esnouf, 1997), and RASTER3D (Merritt and Bacon,
type of RNase III family proteins in eukaryotes. Gene 245, 213–221.1997).
Guarneros, G. (1988). Retroregulation of bacteriophage lambda int
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